"VSports手机版" Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The . gov means it’s official VSports app下载. Federal government websites often end in . gov or . mil. Before sharing sensitive information, make sure you’re on a federal government site. .

Https

The site is secure V体育官网. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely. .

. 2018 Jul;67(7):1113-1121.
doi: 10.1007/s00262-018-2169-1. Epub 2018 May 8.

VISTA expression on tumor-infiltrating inflammatory cells in primary cutaneous melanoma correlates with poor disease-specific survival

Affiliations

VISTA expression on tumor-infiltrating inflammatory cells in primary cutaneous melanoma correlates with poor disease-specific survival

Lawrence F Kuklinski et al. Cancer Immunol Immunother. 2018 Jul.

Abstract

Adaptive immune responses contribute to the pathogenesis of melanoma by facilitating immune evasion. V-domain Ig suppressor of T-cell activation (VISTA) is a potent negative regulator of T-cell function and is expressed at high levels on monocytes, granulocytes, and macrophages, and at lower densities on T-cell populations within the tumor microenvironment. In this study, 85 primary melanoma specimens were selected from pathology tissue archives and immunohistochemically stained for CD3, PD-1, PD-L1, and VISTA. Pearson's correlation coefficients identified associations in expression between VISTA and myeloid infiltrate (r = 0. 28, p = 0. 009) and the density of PD-1+ inflammatory cells (r = 0. 31, p = 0. 005). The presence of VISTA was associated with a significantly worse disease-specific survival in univariate analysis (hazard ratio = 3. 57, p = 0. 005) and multivariate analysis (hazard ratio = 3. 02, p = 0. 02). Our findings show that VISTA expression is an independent negative prognostic factor in primary cutaneous melanoma and suggests its potential as an adjuvant immunotherapeutic intervention in the future. VSports手机版.

Keywords: Checkpoint inhibitor; Melanoma; Survival; Tumor microenvironment; Tumor-infiltrating lymphocytes; VISTA. V体育安卓版.

PubMed Disclaimer

Conflict of interest statement

Randolph J. Noelle is the co-founder of ImmuNext. All other authors declare no conflicts of interest V体育ios版.

Figures

Fig. 1
Fig. 1
Representative immunohistochemical staining patterns. a CD3 expression in TIIC. b VISTA expression in tumor-infiltrating neutrophils and rare mononuclear cells. c PD-L1 expression in melanoma cells. d PD-L1 expression in TIIC. e PD-1 expression in TIIC. f Negative control (original magnification ×400). Arrows indicate positively stained cells
Fig. 2
Fig. 2
Kaplan–Meier disease specific survival curve by VISTA expression in tumor-infiltrating inflammatory cells

References

    1. Garbe C, Eigentler TK, Keilholz U, Hauschild A, Kirkwood JM. Systematic review of medical treatment in melanoma: current status and future prospects. Oncologist. 2011;16(1):5–24. doi: 10.1634/theoncologist.2010-0190. - DOI - PMC - PubMed
    1. Geller AC, Zhang Z, Sober AJ, Halpern AC, Weinstock MA, Miller DR, et al. The first 15years of the American Academy of Dermatology skin cancer screening programs: 1985–1999. J Am Acad Dermatol. 2003;48(1):34–41. doi: 10.1067/mjd.2003.9. - DOI - PubMed
    1. Jemal A, Saraiya M, Patel P, Cherala SS, Barnholtz-Sloan J, Kim J, et al. Recent trends in the cutaneous melanoma incidence and death rates in the United States, 1992–2006. J Am Acad Dermatol. 2011;65(5 Suppl 1):S17–S25. - V体育安卓版 - PubMed
    1. Balch CM, Soong SJ, Gershenwald JE, Thompson JF, Reintgen DS, Cascinelli N, et al. Prognostic factors analysis of 17,600 melanoma patients: validation of the American Joint Committee on Cancer melanoma staging system. J Clin Oncol. 2001;19(16):3622–3634. doi: 10.1200/JCO.2001.19.16.3622. - VSports - DOI - PubMed
    1. Clemente CG, Mihm MC, Jr, Bufalino R, Zurrida S, Collini P, Cascinelli N. Prognostic value of tumor infiltrating lymphocytes in the vertical growth phase of primary cutaneous melanoma. Cancer. 1996;77(7):1303–1310. doi: 10.1002/(SICI)1097-0142(19960401)77:7<1303::AID-CNCR12>V体育ios版 - 3.0.CO;2-5. - DOI - PubMed

MeSH terms